Minnesota Medical Technologies Corporation Announces European Distribution Agreement

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

February 24, 2021

Minnesota Medical Technologies Corporation (Minnesota Medical), a medical device manufacturing company based in Stewartville, MN, U.S, and Wellspect Healthcare (Wellspect), headquartered in Mölndal, Sweden and a part of U.S. based Dentsply Sirona, have entered into an agreement for the distribution of Minnesota Medical’s fecal incontinence insert throughout Europe.

David A. Jonas, Minnesota Medical’s CEO commented: “We are pleased to announce this exciting, strategic partnership with Wellspect.

This collaboration puts our innovative technology in the hands of one of the world’s leading providers of continence care solutions.  Wellspect has the infrastructure and relationships to immediately begin marketing and distributing this life-changing product throughout Europe. Without question, this will accelerate our growth curve.”

The completion of this strategic distribution agreement provides Wellspect the exclusive rights to distribute Minnesota Medical’s innovative fecal incontinence insert device in markets across Europe. The product, which has been approved for sale in Europe, will be marketed under Wellspect’s Navina™ brand.

“Supporting our customers and users is at the heart of everything we do, we are constantly searching for collaborations with companies that have unique and innovative products in our core areas. It is therefore with pleasure that we can now launch the Navina Incontinence Insert, which is the result of our strategic collaboration with Minnesota Medical Technologies,” says Svenn Poulsen, Group Vice President, Wellspect Healthcare.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.